Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients-Reference-Cited by-同舟云学术

Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients

Published:2012-10-17 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Renner Peter¹,Milazzo Stefania¹,Liu Jian Ping²,Zwahlen Marcel³,Birkmann Josef¹,Horneber Markus¹

Affiliation:

1. Klinikum Nord; Medizinische Klinik 5-Schwerpunkt Onkologie/Haematologie; Prof.-Ernst-Nathan-Str. 1 Nuernberg Germany D-90419

2. Beijing University of Chinese Medicine; Centre for Evidence-Based Chinese Medicine; 11 Bei San Huan Dong Lu, Chaoyang District Beijing China 100029

3. University of Bern; Institute of Social and Preventive Medicine; Finkelhubelweg11 Bern Switzerland 3012

Publisher

Wiley

Subject

Pharmacology (medical)

Reference83 articles.

1. Lenograstim prevents morbidity from intensive induction chemotherapy in the treatment of inflammatory breast cancer;Chevallier;Journal of Clinical Oncology,1995

2. Economic evaluation of lenograstim (glycosylated rHuG-CSF) in the treatment of inflammatory breast cancer for Germany and Italy;Mapelli;Pharmacoeconomics,1994

3. Inflammatory breast cancer outcome with epirubicin-based induction and maintenance chemotherapy: ten-year results from the French Adjuvant Study Group GETIS 02 Trial;Veyret;Cancer,2006

4. XM02 is superior to placebo and equivalent to Neupogen in reducing the duration of severe neutropenia and the incidence of febrile neutropenia in cycle 1 in breast cancer patients receiving docetaxel/doxorubicin chemotherapy;Giglio;BMC Cancer,2008

5. Effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) on hematologic toxicity induced by high-dose chemotherapy in patients with metastatic breast cancer;Hansen;Acta Oncologica,1995

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chinese Medicine Combined with Adjuvant Chemotherapy for Improving Myelosuppression in Colorectal Cancer Patients: A Systematic Review and Network Meta-Analysis;Chinese Journal of Integrative Medicine;2024-01-12

2. Prospective Observational Study on the Risk Factors of Chemotherapy-Induced Myelosuppression and Its Management in a Tertiary Care Hospital;Indian Journal of Medical and Paediatric Oncology;2023-07-05

3. Febrile neutropenia incidence and the variable toxicity profile between brand and generic docetaxel in the adjuvant treatment of breast cancer with docetaxel and cyclophosphamide regimen;einstein (São Paulo);2023

4. Effects of primary granulocyte-colony stimulating factor prophylaxis on neutropenic toxicity and chemotherapy dose delivery in Chinese patients with breast cancer who received adjuvant docetaxel plus cyclophosphamide chemotherapy: a retrospective cohort study;Hong Kong Medical Journal;2022-10-20

5. Maximum daily dose of G-CSF is critical for preventing recurrence of febrile neutropenia in patients with gynecologic cancer: A case–control study;Medicine;2022-08-26